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Abstract
AIM: To determine gastric emptying, blood pressure, 
mesenteric artery blood flow, and blood glucose 
responses to oral glucose in Parkinson’s disease. 
METHODS: Twenty-one subjects (13 M, 8 F; age 
64.2 ± 1.6 years) with mild to moderate Parkinson’
s disease (Hoehn and Yahr score 1.4 ± 0.1, duration 
of known disease 6.3 ± 0.9 years) consumed a 75 
g glucose drink, labelled with 20 MBq 99mTc-calcium 
phytate. Gastric emptying was quantified with 
scintigraphy, blood pressure and heart rate with an 
automated device, superior mesenteric artery blood 
flow by Doppler ultrasonography and blood glucose by 
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Basic Study
Gastric emptying, postprandial blood pressure, glycaemia 
and splanchnic flow in Parkinson’s disease
the cohorts studied and the methodology used to 
quantify GE. Delayed GE has been associated with 
upper gastrointestinal and motor symptoms, as well as 
impaired absorption of dopaminergic therapy[3,4]. 
There is little or no information about the potential 
impact of GE in two other areas: postprandial blood 
pressure (BP) and glycaemia. Postprandial hypotension 
(PPH), a fall in systolic BP of ≥ 20 mmHg within 2 h 
of a meal[5], was reported for the first time in 1977 
in a patient with PD[6] and is a clinically important 
disorder, predisposing to syncope and falls and being 
associated with increased mortality[7]. PPH may occur 
frequently in PD, but information is limited[8]. It has 
also been suggested that PPH represents an “early” 
marker of autonomic dysfunction in PD[8,9]. Our studies 
have established that GE is pivotal to the regulation 
of postprandial BP- in healthy older subjects and 
patients with type 2 diabetes, the magnitude of the 
hypotensive response is greater when GE is relatively 
faster[10]. When glucose is infused intraduodenally in 
healthy older subjects at 1, 2 or 3 kcal/min, there is a 
substantial fall in systolic BP in response to the 2 and 
3 kcal/min, but not the 1 kcal/min, load[11]. In contrast 
to the effect of GE, gastric distension attenuates the 
fall in BP[12], and consumption of water has been 
advocated as a treatment for PPH[7]. Only one study 
has evaluated the impact of GE on BP in PD and found 
no relationship in a cohort of 12 patients with mild to 
moderate disease[13]; BP was not a primary outcome 
in this study. The hypotensive response to a meal 
may relate to splanchnic blood pooling, as assessed 
by measurement of superior mesenteric artery (SMA) 
blood flow using Doppler ultrasound[14]. 
GE is an important determinant of postprandial 
glycaemia, which is a major contributor to “overall” 
glycaemic control in diabetes, as assessed by glycated 
hemoglobin[15]. Accordingly, in health[16], subjects with 
impaired glucose tolerance[16,17] and type 2 diabetes[17], 
when GE is faster, there is a greater initial glycaemic 
response. While diabetes per se does not appear to 
increase the propensity to PD[18], type 2 diabetes may 
be associated with greater impairments in postural 
stability and gait[19]. PD is associated with impaired 
insulin signalling in the brain[20] and drugs develo-
ped for the management of diabetes, particularly 
glucagon-like peptide-1 agonists, may have efficacy in 
treatment[21]. There is no information about the impact 
of GE on postprandial glycaemia in PD.
The primary aims of this study were to quantify 
the GE, BP, SMA flow and blood glucose responses to 
oral glucose in mild to moderate PD and evaluate the 
relationships of changes in BP and glycaemia with the 
rate of GE. We hypothesised that there would be a 
high prevalence of delayed GE, that consumption of 
glucose would result in a fall in BP and rises in both 
SMA flow and blood glucose, and that these responses 
would be related to GE.
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glucometer for 180 min. Autonomic nerve function was 
evaluated with cardiovascular reflex tests and upper 
gastrointestinal symptoms by questionnaire. 
RESULTS: The mean gastric half-emptying time was 
106 ± 9.1 min, gastric emptying was abnormally 
delayed in 3 subjects (14%). Systolic and diastolic 
blood pressure fell (P  < 0.001) and mesenteric 
blood flow and blood glucose (P  < 0.001 for both) 
increased, following the drink. Three subjects (14%) 
had definite autonomic neuropathy and 8 (38%) had 
postprandial hypotension. There were no significant 
relationships between changes in blood pressure, 
heart rate or mesenteric artery blood flow with gastric 
emptying. Gastric emptying was related to the score for 
autonomic nerve function (R  = 0.55, P  < 0.01). There 
was an inverse relationship between the blood glucose 
at t  = 30 min (R  = -0.52, P  < 0.05), while the blood 
glucose at t  = 180 min was related directly (R  = 0.49, 
P  < 0.05), with gastric emptying. 
CONCLUSION: In mild to moderate Parkinson’s disease, 
gastric emptying is related to autonomic dysfunction and 
a determinant of the glycaemic response to oral glucose. 
Key words: Gastric emptying; Hypotension; Parkinson’s 
disease; Blood pressure; Glucose
© The Author(s) 2016. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: We measured gastric emptying, blood pressure 
and blood glucose responses to a glucose drink in 21 
patients with mild-to-moderate Parkinson’s disease. 
Gastric emptying was shown to be abnormally delayed 3 
patients and 40% had postprandial hypotension - a fall 
in systolic blood pressure > 20 mmHg after the glucose 
drink. We demonstrated relationships between gastric 
emptying and autonomic dysfunction, so that slower 
gastric emptying was associated with greater autonomic 
dysfunction, as well as relationships between the blood 
glucose response with gastric emptying.
Trahair LG, Kimber TE, Flabouris K, Horowitz M, Jones KL. 
Gastric emptying, postprandial blood pressure, glycaemia and 
splanchnic flow in Parkinson’s disease. World J Gastroenterol 
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INTRODUCTION
While gastrointestinal dysfunction occurs frequently 
in Parkinson’s disease (PD)[1,2], the prevalence of 
abnormally delayed gastric emptying (GE) remains 
uncertain because of substantial variations in both 
MATERIALS AND METHODS
Subjects
Twenty one subjects with mild to moderate PD were 
recruited through advertisements placed in a local 
Parkinson’s newsletter, and outpatient referral by a 
neurologist (TK). Mild to moderate PD was defined as a 
score ≤ 2.5 on the modified Hoehn and Yahr scale[22]. 
Subjects who were unable to move independently, 
or who had a history of falls, gastrointestinal disease 
(unrelated to Parkinson’s), diabetes, significant 
respiratory or cardiac disease, alcohol abuse or epilepsy, 
were excluded. 13 males and 8 females, age 64.2 ± 
1.6 years (range: 51-77 years), body mass index (BMI) 
25.2 ± 0.8 kg/m2 (range: 20.3-34.5 kg/m2) and known 
duration of PD 6.3 ± 0.9 years (range: 1-16 years), 
were studied. Two patients were receiving antihy-
pertensive drugs, which were withdrawn for 24 h before 
the study day. Details of anti-Parkinsonian medication 
are summarised in Table 1. Four subjects had received 
deep brain stimulation for the management of their PD.
Protocol
At an initial screening visit 6-65 d before the study day, 
a medical history and staging of Parkinson’s symptoms 
on the modified Hoehn and Yahr scale were performed 
by a neurologist (TK)[22] and a questionnaire to asses 
symptoms referrable to delayed GE completed[23,24].
On the study day, subjects attended the Depart-
ment of Nuclear Medicine, Positron Emission Tomo-
graphy and Bone Densitometry at the Royal Adelaide 
Hospital at 0830h after an overnight fast from solids 
(14 h) and liquids (12 h). Where possible, subjects 
were asked to withhold the morning dose of anti-Parkin-
sonian medication. On arrival, the subject was seated 
in front of a gamma camera and an IV cannula inserted 
into the left antecubital vein for blood sampling. An 
automated cuff was placed around the upper right 
arm to measure BP and HR. The subject was then 
allowed to “rest” for approximately 15 min[11]. At t = 
-3 min, the subject consumed a drink comprising 75 g 
glucose and 5 g 3-O-Methyl-D-gluco-pyranose (3-OMG) 
(Carbosynth, Berkshire, United Kingdom) dissolved 
in water (total drink volume 300 mL), labelled with 
20 MBq 99mTc-calcium phytate (Radpharm Scientific, 
Belconnen, ACT, Australia) within 3 min. GE, BP, SMA 
blood flow and blood glucose were measured for 
180 min following the drink. At t = 180 min, the IV 
cannula was removed and the subject given a meal. 
Evaluation of autonomic function, using standardised 
cardiovascular reflex tests[25], was then performed, 
prior to the subject leaving the laboratory. 
The protocol was approved by the Research Ethics 
Committee of the Royal Adelaide Hospital, and each 
subject provided written, informed consent prior to 
their inclusion. All experiments were carried out in 
accordance with the Declaration of Helsinki. 
Measurements
Gastric emptying: Radioisotopic data was acquired 
for 180 min following consumption of the drink (60 s 
frames between t = 0-60 min, then 180 s frames from 
t = 60-180 min), where t = 0 was the time of com-
pletion of the drink. Data were corrected for subject 
movement, radionuclide decay and γ-ray attenuation[26]. 
A region-of-interest was drawn around the total 
stomach and gastric emptying curves (expressed as 
percentage retention over time) derived. The amount 
of the drink remaining in the total stomach at 15 min 
intervals between t = 0-180 min, as well as the 50% 
gastric emptying time (T50)[26], were calculated. The 
normal range for the T50 of this drink is 43-157 min, 
based on data in 21 healthy subjects (age 64.8 ± 1.8 
years), matched for age (i.e., within 2 years) to each 
subject with PD[17]. GE was considered to be abnormally 
fast or slow when the T50 was above, or below, this 
normal range.
Blood pressure and heart rate: BP and HR were 
measured using an automated BP monitor (DINAMAP 
ProCare 100, GE Medical Systems, Milwaukee, WI, 
United States), every 3 min during the “rest” period, 
and from t = 0-180 min. Baseline BP was calculated 
as an average of the three measurements obtained 
immediately prior to the consumption of the drink (i.e., 
t = -9, t = 6 and t = -3 min)[11]. Maximum changes in 
BP and HR were calculated as the greatest change that 
occurred from baseline. Subjects were categorised 
according to the maximum fall in systolic BP following 
the drink, i.e., those in which the fall was ≤ 10 mmHg, 
> 10 mmHg but < 20 mmHg and ≥ 20 mmHg. PPH 
was defined as a sustained (> 10 min) fall in systolic 
BP of ≥ 20 mmHg[5]. 
Superior mesenteric artery blood flow: SMA flow 
was measured using a LogiqTM e ultrasound system (GE 
Healthcare Technologies, Sydney, NSW, Australia) and 
a 3.5C broad spectrum 2.5-4 MHz convex linear array 
transducer. Measurements were obtained immediately 
prior to the consumption of the drink (t = -3 min), 
every 15 min between t = 0-60 min, and then at t = 
90 min, 120 min and 180 min. Blood flow (mL/min) 
was calculated automatically using the formula: π × 
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Table 1  List of anti-Parkinsonian medications in 21 patients 
with Parkinson’s disease  n  (%)
Drug Patients
Pramipexole 11 (52)
Levodopa   9 (43)
Levodopa and Carbidopa   8 (38)
Levodopa, Carbidopa and Entacapone   4 (19)
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overall linear pattern. A P value < 0.05 was considered 
significant in all analyses. The number of subjects 
included was based on power calculations derived 
from our previous study[10]. The statistical analysis 
was supervised and reviewed by a professional 
biostatistician. Data are presented as mean ± SE. 
RESULTS
The studies were well tolerated and no adverse events 
were reported. The mean Hoehn and Yahr score was 
1.4 ± 0.1 (range: 1-2.5) and duration of known PD 6.3 
± 0.9 years (range: 1-16 years). Three subjects were 
unwilling, or unable to withhold their morning anti-
Parkinson medications because of the risk of significant 
motor dysfunction. Three subjects had definite 
autonomic neuropathy, in 10 subjects the score was ≥ 
2; the mean ANF score was 1.8 ± 0.3 (range: 0-5); 5 
subjects had OH. Eight subjects had PPH. In another 
8, the maximum fall was > 10 mmHg but < 20 mmHg 
and in 5 subjects the fall was < 10 mmHg. Four of the 
5 subjects with OH also had PPH. The mean score for 
upper gastrointestinal symptoms was 1.5 ± 0.4 (range: 
0-5).
Gastric emptying
Gastric emptying of the drink approximated an overall 
linear pattern. The T50 was 106 ± 9.1 min. In three 
subjects, GE (T50) was abnormally slow; no subject 
had abnormally rapid GE. 
Blood pressure and heart rate
Baseline systolic BP was 116.9 ± 2.4 mmHg. Following 
the drink, there was a transient modest rise, followed 
by a fall, in systolic BP (P < 0.001, Figure 1A), 
which was sustained until the end of the study. The 
maximum fall was -18.6 ± 2.0 mmHg, occurring at t = 
76.5 ± 12.8 min. 
Baseline diastolic BP was 69.1 ± 1.6 mmHg. 
Following the drink, there was a transient initial rise, 
and then a fall, in diastolic BP (P < 0.001, Figure 
1B), with a nadir between t = 30-45 min, which was 
sustained until the end of the study. The maximum fall 
in diastolic BP was -15.6 ± 0.9 mmHg, occurring at t = 
85.9 ± 11.6 min. 
Baseline heart rate was 69.5 ± 2.1 BPM. Following 
the drink, there was an increase in heart rate (P < 
0.001, Figure 1C), which had returned to baseline by 
approximately t = 60 min. The maximum increase in 
HR was 9.5 ± 0.7 BPM occurring at 75.6 ± 13.3 min. 
Superior mesenteric artery blood flow
Baseline SMA flow was 565.0 ± 62.5 mL/min. Following 
the drink, there was a prompt increase in SMA flow (P 
< 0.001, Figure 2), which had returned to baseline by 
t = 180 min. The maximum SMA flow was 1208.8 ± 
123.0 mL/min, occurring at t = 54.8 ± 8.1 min. 
r2 × TAMV × 60, where R = the radius of the SMA 
and TAMV is the time-averaged mean velocity[14]. 
In all subjects two measurements were acquired by 
the same, experienced investigator (LT) at each time 
point.
Blood glucose: Venous blood was sampled imme-
diately prior to the consumption of the drink (t = -3 
min), every 15 min between t = 0-60 min and then 
at t = 90 min, 120 min and 180 min. Blood glucose 
(mmol/L) was determined immediately using a 
portable glucometer (Medisense Companion 2 m, 
Medisense Inc. Waltham, MA, United States). Results 
were classified, according to World Health Organisation 
criteria, as normal glucose tolerance (NGT) (fasting 
blood glucose < 6.1 mmol/L, and 2 h < 7.8 mmol/L), 
impaired fasting glucose (IFG) (fasting blood glucose 
< 7.0 mmol/L, but > 6.1 mmol/L), impaired glucose 
tolerance (IGT) (2 h blood glucose < 11.1 mmol/L, but 
> 7.8 mmol/L), or diabetes (fasting blood glucose ≥ 7.0 
mmol/L and/or 2 h blood glucose ≥ 11.1 mmol/L)[27].
Upper gastrointestinal symptoms: Upper 
gastrointestinal symptoms assessed at the screening 
visit by questionnaire[23], included anorexia, nausea, 
early satiety, bloating, vomiting, abdominal pain, 
dysphagia, heart burn and acid regurgitation. Each 
was scored as: 0 = none, 1 = mild, 2 = moderate or 3 
= severe, for a maximum score of 27[23].
Cardiovascular autonomic nerve function: 
Autonomic nerve function (ANF) was assessed using 
standardised cardiovascular reflex tests[25]. Parasy-
mpathetic function was evaluated by the variation (R-R 
interval) of the heart rate during deep breathing and 
the response to standing (“30:15” ratio). Sympathetic 
function was assessed by the fall in systolic BP in 
response to standing. Each of the results was scored 
according to age-adjusted predefined criteria as 0 = 
normal, 1 = borderline and 2 = abnormal for a total 
maximum score of 6. A score ≥ 3 was considered 
to indicate definite autonomic dysfunction[25,28]. 
Orthostatic hypotension (OH) was defined as a 
sustained reduction in systolic BP of > 20 mmHg 
within 3 min of standing[29].
Statistical analysis: BP and HR were assessed as 
changes from baseline, whereas GE, SMA flow and 
blood glucose were analysed as absolute values. The 
maximum changes from baseline in BP, HR and blood 
glucose were also calculated. Areas under the curve 
(AUCs) were calculated for BP, HR, SMA flow and 
blood glucose using the trapezoidal rule. Changes 
in each variable over time were evaluated with 
ANOVA. Pearson’s correlation was used to evaluate 
relationships between variables. Relationships of BP, 
upper gastrointestinal symptoms and glycaemia with 
GE were assessed using the GE T50, given the observed 
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Blood glucose
Baseline blood glucose was 5.6 ± 0.1 mmol/L. 
Following the drink, there was an increase in blood 
glucose (P < 0.001, Figure 3), which had returned to 
baseline by t = 180 min. The maximum blood glucose 
was 10.2 ± 0.5 mmol/L, occurring at 48.9 ± 4.0 min. 
Five subjects had IGT, 2 had both IFG and IGT and 1 
had “marginal” diabetes (fasting and 2 h blood glucose 
of 7.1 mmol/L and 11.1 mmol/L, respectively).
Relationships between variables
There were no significant relationships between the 
changes in systolic BP, diastolic BP, HR or SMA flow at 
any time point (absolute values and AUCs). The T50 
was related directly to the ANF score (R = 0.55, P < 
0.01, Figure 4). Upper gastrointestinal symptoms were 
also related to the score for ANF (R = 0.45, P < 0.05), 
but not GE.
There was an inverse relationship between the 
blood glucose at t = 30 min (R = -0.52, P < 0.05, 
Figure 5), while the blood glucose at t = 180 min (but 
not 120 min) was related directly (R = 0.49, P < 0.05) 
to the T50. 
There were no significant relationships between 
T50, Hoehn and Yahr score, duration of disease, or 
age.
DISCUSSION
Our study has quantified the GE, BP, SMA and gly-
caemic responses to oral glucose in mild to moderate 
4864 May 28, 2016|Volume 22|Issue 20|WJG|www.wjgnet.com
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Figure 1  Systolic blood pressure (A), diastolic blood pressure (B) and 
heart rate (C) immediately before and after 75 g oral glucose load in 21 
patients with Parkinson’s disease. BP: Blood pressure.
SMA blood flow
0            30           60           90           120         150         180










Figure 2  Superior mesenteric artery blood flow immediately before and 
after 75 g oral glucose load in 21 patients with Parkinson’s disease. SMA: 
Superior mesenteric artery.
Blood glucose
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Figure 3  Blood glucose immediately before and after 75 g oral glucose 
load in 21 patients with Parkinson’s disease.
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PD. In the majority of patients, oral glucose induced a 
significant fall in systolic BP; i.e., in 16 of 21 patients 
(76%), this fall was > 10 mmHg and 8 (38%) had 
PPH. GE of glucose was abnormally delayed in 3 
patients (14%), a prevalence lower than we anticipated 
and slower in those patients with cardiovascular 
autonomic neuropathy, and gastric emptying was not 
accelerated in any subject. There was, however, no 
relationship between the magnitude of the fall in BP 
with GE. A relationship between the initial glycaemic 
response to glucose with GE, comparable to that 
observed in subjects without PD, was demonstrated.
The outcome of studies relating to the prevalence of 
disordered GE in PD is inconsistent. We measured GE 
using the “gold-standard” technique of scintigraphy and, 
while a liquid, rather than a solid, “meal” was used, 
the precision of solid and high-nutrient liquid meals in 
the diagnosis of delayed GE appears comparable[30]. 
It should, however, be recognised that our definition 
of delayed GE - a T50 that was greater than the 
range observed in healthy subjects, was deliberately 
stringent, so that more modest gastric motor function 
cannot be excluded. The observations of a relationship 
between GE and the severity of autonomic dysfunction 
and the high prevalence of autonomic dysfunction are 
not surprising. The pathophysiology of disordered GE 
in PD is heterogeneous - alpha-synuclein aggregation, 
abnormalities in the dorsal motor nucleus of the 
vagus and enteric nervous system, and drugs such 
as L-dopa may all be important[2]. As with previous 
studies, there was no significant relationship between 
GE and the duration of PD[31]. Patients had mild upper 
gastrointestinal symptoms, possibly in part because 
the majority were studied off dopaminergic therapy, 
although symptoms were more common in patients 
with impaired ANF.
The high prevalence of PPH is comparable to 
that reported previously - 8 subjects had PPH and 
the fall in systolic BP was ≥ 10 mmHg in 16 of 21 
(76%) subjects[8]. That the latter may have adverse 
consequences, even in apparently “asymptomatic” 
patients[32], dictates the need for greater recognition. 
We did not observe a relationship between the 
magnitude of the fall in BP and GE, for which there are 
a number of potential explanations. Baseline systolic 
BP was in most cases “normal”, which is predictive of 
a smaller postprandial fall[33]. We have demonstrated 
in healthy older subjects that the relationship between 
the fall in BP and the rate of duodenal glucose delivery 
is non-linear, so that a “threshold” between 1-2 
kcal/min must be exceeded to elicit a hypotensive 
response[11]. In the current study, based on the T50, GE 
was ≥ 2 kcal/min in only 4 subjects. Hence, it would 
be appropriate to re-evaluate this hypothesis further in 
a larger group of patients. The current study certainly 
does not exclude the possibility that PD patients with 
relatively more rapid GE are at increased risk for PPH.
There was an approximate doubling in SMA flow 
following the glucose drink, as anticipated. In healthy 
subjects and patients with autonomic failure[34], 
comparable increases in SMA flow have been ob-
served, but a reduction in BP was only evident in 
patients with autonomic failure, probably reflecting 
inadequate sympathetic compensation[34]. The absence 
of a relationship between BP and SMA flow, may 
reflect the relatively narrow distribution of the rises 
in SMA flow, and modest size of the cohort. OH is a 
frequent manifestation of autonomic involvement in 
PD and a concordance of PPH and OH in PD has been 
reported[8], and supported by our study. 
The relationship between the initial glycaemic 
response to the drink and the rate of GE in PD is 
consistent with observations in health[16], impaired 
glucose tolerance[16,17], and type 2 diabetes[17] as 
well as the effect of delayed GE on the absorption of 
L-dopa in PD[2]. It is now recognised that postprandial 
glycaemic excursions are a major determinant of 
overall glycaemic control in type 2 diabetes, assuming 
increasing importance as glycated hemoglobin 
normalises[15]. Eight of our 21 subjects (38%) had 
either impaired glucose tolerance (7 subjects) or 
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Figure 4  Relationship between gastric half emptying time (GE T50) and 
autonomic nerve function score (R = 0.55, P < 0.01). ANF: Autonomic nerve 
function.
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R  = -0.52, P  < 0.05
Figure 5  Relationship between the absolute blood glucose at t = 30 min 
with the gastric half emptying time (GE T50) (R = -0.52, P < 0.05).
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“marginal” diabetes (1 subject); that the blood glucose 
level at 180 min, but not 120 min, was inversely, 
rather than directly, related to GE, presumably reflects 
higher insulin levels achieved earlier, associated 
with insulin resistance[16]. In healthy subjects an 
inverse relationship is evidence at 120 min after a 
75 g oral glucose load[17]. The recognition that GE is 
a determinant of glycaemia in PD is not surprising, 
but potentially important- slower GE, including that 
induced by dopaminergic therapy, would potentially be 
advantageous in optimising glycaemic control in type 
2 patients with PD. Interestingly, GLP-1 agonists, such 
as exenatide BD which are undergoing evaluation of 
their efficacy in the management of PD[21], diminish 
postprandial glycaemic excursions primarily by slowing 
GE[35].
In interpreting our observations, it should be 
recognised that 3 subjects did not withdraw their 
medication, which may represent a cofounder. We 
also did not include a control (water) drink because 
of potential ethical concerns. A normal range for GE 
allowed the prevalence of disordered GE in PD to be 
determined - a formal control group was not included 
because the focus of the present study was on 
relationships between variables within the Parkinson’s 
group. As discussed, one subject had diabetes, based 
on fasting and 2 h blood glucose, but these levels were 
only marginally above the diagnostic cut-offs and this 
subject was not excluded.
In conclusion, in this unselected population of 
patients with mild to moderate PD, GE was delayed 
in only a minority, oral glucose induced a substantial 
reduction in BP, as well as rises in SMA flow and blood 
glucose, and GE was an important determinant of the 
glycaemic, but not the BP, response.
COMMENTS
Background
Delayed gastric emptying is recognised as a sequela of Parkinson’s disease 
(PD), but its prevalence remains uncertain and the potential impact on 
both postprandial blood pressure and glycaemia have not been evaluated. 
Postprandial hypotension is known to occur frequently in PD and may be 
influenced by changes in superior mesenteric artery blood flow.
Research frontiers
Delayed gastric emptying in PD is associated with fluctuations in motor 
response, upper gastrointestinal symptoms and impaired absorption of 
dopaminergic therapy. The pathophysiology of postprandial hypotension is 
poorly defined, but the magnitude of the fall in blood pressure is known to 
be dependent on the rate of gastric emptying as well as changes in superior 
mesenteric artery blood flow.
Innovations and breakthroughs
The outcome of studies investigating the prevalence of disordered gastric 
emptying in PD have been inconsistent, at least in part reflecting variations in 
the cohorts studied and methodology employed to measure gastric emptying. 
The authors have measured gastric emptying using the “gold-standard” 
technique of scintigraphy in a well defined cohort of patients with PD to address 
these limitations. Furthermore, no study in PD has assessed changes in blood 
pressure and superior mesenteric artery blood flow following oral glucose. 
Applications
The recognition that gastric emptying is a determinant of glycaemia is of 
importance to the management of glycaemic control in patients with PD who have 
type 2 diabetes. The authors identified a high prevalence of postprandial 
hypotension in this population, and given the substantial adverse sequale 
associated with this condition, this represents an important consideration in the 
management of PD with likely autonomic involvement.
Terminology
Postprandial hypotension, a fall in systolic blood pressure > 20 mmHg occurring 
within two hours of a “meal”. 
Peer-review
This is an excellent manuscript which comprehensively describes a very well-
conducted investigation that is clinically relevant.
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